Ixensor Co

Ixensor Co EBIT Growth

The Year-over-Year EBIT Growth of Ixensor Co (6734.TWO) as of Oct 21, 2026 is 0.81 %. In the previous year, Year-over-Year EBIT Growth was 26.89 % — a change of -97.01% (lower).

EBIT Growth

0.81 %

YoY

-97.01%

Last updated:

Year-over-Year EBIT Growth of Ixensor Co is 2025 0.81 % . Year-over-Year EBIT Growth of Ixensor Co was 2024 26.89 % . It decreases by -97.01% lower compared to the previous year.

The Ixensor Co EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
-0.40 TWD
Jan 1, 2019
0.27 TWD
Jan 1, 2020
26.60 TWD
Jan 1, 2021
-1.81 TWD
Jan 1, 2022
93.58 TWD
Jan 1, 2023
-1,104.82 TWD
Jan 1, 2024
26.89 TWD
Jan 1, 2025
0.81 TWD
The Ixensor Co EBIT Growth history
YEAREBIT GrowthYoY
0.81 %-97.01%
26.89 %-102.43%
-1,104.82 %-1,280.63%
93.58 %-5,257.66%
-1.81 %-106.82%
26.60 %+9,929.71%
0.27 %-166.86%
-0.40 %-85.50%
-2.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ixensor Co Stock analysis

What does Ixensor Co do? iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring. Ixensor Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ixensor Co stock

Year-over-Year EBIT Growth of Ixensor Co is 0.81 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Ixensor Co since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Ixensor Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Ixensor Co

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Ixensor Co